These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 15217709)
1. [Recommendations for the cytogenetic management of adult malignant non-Hodgkin lymphoma proposed by the French Group for Cytogenetic Hematology]. Groupe Français de Cytogénétique Hématologique (GFCH) Pathol Biol (Paris); 2004 Jun; 52(5):260-2. PubMed ID: 15217709 [No Abstract] [Full Text] [Related]
2. [Recommendations for the cytogenetic management of non-Hodgkin lymphoma in children <18 years old proposed by the French Group for Cytogenetic Hematology]. Groupe Français de Cytogénétique Hématologique (GFCH) Pathol Biol (Paris); 2004 Jun; 52(5):257-9. PubMed ID: 15217708 [No Abstract] [Full Text] [Related]
3. [Recommendations for the cytogenetic management of adult and childhood acute lymphoblastic leukemia (ALL) proposed by the French Group for Cytogenetic Hematology]. Groupe Français de Cytogénétique Hématologique (GFCH) Pathol Biol (Paris); 2004 Jun; 52(5):251-3. PubMed ID: 15217706 [No Abstract] [Full Text] [Related]
4. [Recommendations for the cytogenetic management of multiple myeloma proposed by the French Group for Cytogenetic Hematology]]. Groupe Français de Cytogénétique Hématologique (GFCH) Pathol Biol (Paris); 2004 Jun; 52(5):263-4. PubMed ID: 15217710 [No Abstract] [Full Text] [Related]
5. [Recommendations for the cytogenetic management of acute myeloblastic leukemia established by the French Group for Cytogenetic Hematology]. Groupe Français de Cytogénétique Hématologique (GFCH) Pathol Biol (Paris); 2004 Jun; 52(5):248-50. PubMed ID: 15217705 [No Abstract] [Full Text] [Related]
6. [Recommendations for the cytogenetic management of myeloproliferative syndromes proposed by the French Group for Cytogenetic Hematology]. Groupe Français de Cytogénétique Hématologique (GFCH) Pathol Biol (Paris); 2004 Jun; 52(5):241-4. PubMed ID: 15217703 [No Abstract] [Full Text] [Related]
7. [Recommendations for the cytogenetic management of myelodysplastic syndrome by the French Group fo Cytogenetic Hematology]. Groupe Français de Cytogénétique Hématologique (GFCH) Pathol Biol (Paris); 2004 Jun; 52(5):245-7. PubMed ID: 15217704 [No Abstract] [Full Text] [Related]
8. [Recommendations for the cytogenetic management of chronic lymphocytic leukemia established by the French Group for Cytogenetic Hematology]. Groupe Français de Cytogénétique Hématologique (GFCH) Pathol Biol (Paris); 2004 Jun; 52(5):254-6. PubMed ID: 15217707 [No Abstract] [Full Text] [Related]
9. [Introduction to recommendations for the cytogenetic management of hematopoietic diseases]. Dastugue N; Pathol Biol (Paris); 2004 Jun; 52(5):235-7. PubMed ID: 15217701 [No Abstract] [Full Text] [Related]
10. [Recommendations for the cytogenetic management of chronic myeloid leukemia (CML) proposed by the French Group for Cytogenetic Hematology]. Dastague N; Pathol Biol (Paris); 2004 Jun; 52(5):238-40. PubMed ID: 15217702 [No Abstract] [Full Text] [Related]
11. Absence of MALT1 translocations in primary cutaneous marginal zone B-cell lymphoma. Espinet B; Gallardo F; Pujol RM; Estrach T; Servitje O; Solé F Haematologica; 2004 Sep; 89(9):ELT14. PubMed ID: 15377491 [TBL] [Abstract][Full Text] [Related]
12. Fluorescence in situ hybridization improves the detection of 5q31 deletion in myelodysplastic syndromes without cytogenetic evidence of 5q-. Mallo M; Arenillas L; Espinet B; Salido M; Hernández JM; Lumbreras E; del Rey M; Arranz E; Ramiro S; Font P; González O; Renedo M; Cervera J; Such E; Sanz GF; Luño E; Sanzo C; González M; Calasanz MJ; Mayans J; García-Ballesteros C; Amigo V; Collado R; Oliver I; Carbonell F; Bureo E; Insunza A; Yañez L; Muruzabal MJ; Gómez-Beltrán E; Andreu R; León P; Gómez V; Sanz A; Casasola N; Moreno E; Alegre A; Martín ML; Pedro C; Serrano S; Florensa L; Solé F Haematologica; 2008 Jul; 93(7):1001-8. PubMed ID: 18591625 [TBL] [Abstract][Full Text] [Related]
13. Non-Hodgkin's lymphoma of mucosa-associated lymphoid tissue. Cohen SM; Petryk M; Varma M; Kozuch PS; Ames ED; Grossbard ML Oncologist; 2006; 11(10):1100-17. PubMed ID: 17110630 [TBL] [Abstract][Full Text] [Related]
14. Immunoglobulin light chain gene translocations in non-Hodgkin's lymphoma as assessed by fluorescence in situ hybridisation. Fujimoto Y; Nomura K; Fukada S; Shimizu D; Shimura K; Matsumoto Y; Horiike S; Nishida K; Shimazaki C; Abe M; Taniwaki M Eur J Haematol; 2008 Feb; 80(2):143-50. PubMed ID: 18005388 [TBL] [Abstract][Full Text] [Related]
15. Management of nodal indolent (non marginal-zone) non-Hodgkin's lymphomas: practice guidelines from the Italian Society of Hematology, Italian Society of Experimental Hematology and Italian Group for Bone Marrow Transplantation. Barosi G; Carella A; Lazzarino M; Marchetti M; Martelli M; Rambaldi A; Tarella C; Vitolo U; Zinzani PL; Tura S Haematologica; 2005 Sep; 90(9):1236-57. PubMed ID: 16154848 [TBL] [Abstract][Full Text] [Related]
16. Karyotyping lymph node biopsies in non-Hodgkin's lymphoma. Ross FM; Harrison CJ Methods Mol Med; 2005; 115():93-107. PubMed ID: 15998964 [TBL] [Abstract][Full Text] [Related]
17. [Cytogenetics of malignant lymphomas in the year 2000]. Quesnel B Bull Cancer; 2000 Jan; 87(1):25-7. PubMed ID: 10673628 [No Abstract] [Full Text] [Related]
18. Investigation of bone marrow involvement in malignant lymphoma using fluorescence in situ hybridization: possible utility in the detection of micrometastasis. Huh HJ; Min HC; Cho HI; Chae SL; Lee DS Cancer Genet Cytogenet; 2008 Oct; 186(1):1-5. PubMed ID: 18786435 [TBL] [Abstract][Full Text] [Related]
19. Cytogenetics and fluorescence in situ hybridization studies of diffuse large B-cell lymphoma in children and young adults. Dave BJ; Weisenburger DD; Higgins CM; Pickering DL; Hess MM; Chan WC; Sanger WG Cancer Genet Cytogenet; 2004 Sep; 153(2):115-21. PubMed ID: 15350300 [TBL] [Abstract][Full Text] [Related]
20. Clinical activity of rituximab in gastric marginal zone non-Hodgkin's lymphoma resistant to or not eligible for anti-Helicobacter pylori therapy. Martinelli G; Laszlo D; Ferreri AJ; Pruneri G; Ponzoni M; Conconi A; Crosta C; Pedrinis E; Bertoni F; Calabrese L; Zucca E J Clin Oncol; 2005 Mar; 23(9):1979-83. PubMed ID: 15668468 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]